rs2274327 — CA6 Thr55Met

Reduces salivary carbonic anhydrase VI (gustin) secretion, impairing oral acid buffering and increasing susceptibility to dental caries

See your personal result for CA6

Upload your DNA data to find out which genotype you carry and what it means for you.

Upload your DNA data

Works with 23andMe, AncestryDNA, and other DNA test exports. Results in under 60 seconds.

CA6 Thr55Met — Saliva's Acid Defense and the Gustin Connection

Every time you eat fermentable carbohydrates, bacteria in dental plaque produce lactic acid that drops plaque pH below the critical threshold for tooth enamel dissolution (around pH 5.5). The difference between a person who rarely gets cavities and one who consistently does often comes down to how quickly that acid gets neutralized. Saliva is the primary defense — specifically, the bicarbonate 11 Bicarbonate (HCO3-) is the main salivary buffer: it reacts with protons to form carbonic acid, which then breaks down to CO2 and water, neutralizing acidity buffering system. And at the center of that system sits a zinc metalloenzyme called carbonic anhydrase VI, also known as gustin.

CA6 is one of the most abundant proteins in parotid saliva, comprising roughly 3% of total parotid salivary protein. It catalyzes the reversible hydration of carbon dioxide (CO2 + H2O ⇌ HCO3- + H+), accelerating the generation of bicarbonate in the salivary gland acini and in dental plaque itself. Beyond its buffering role, CA6 (gustin) is essential for the growth and maintenance of taste papillae 22 Fungiform papillae are the mushroom-shaped structures on the tongue that house taste buds; low CA6 activity reduces papilla density and impairs taste acuity and acts as a zinc-transport protein in saliva, making it a key node in oral zinc homeostasis.

The Mechanism

The rs2274327 C>T variant causes a missense change at amino acid position 55 of the CA6 precursor protein (p.Thr55Met on the NP_001206 transcript), substituting threonine with methionine. This region lies within exon 2 of the CA6 gene, in a part of the mature secreted enzyme that appears critical for stable folding or secretion efficiency.

The key functional consequence is not a change in catalytic activity — studies examining enzyme kinetics in T-allele carriers find no difference in the rate at which CA VI converts CO2 to bicarbonate 33 Aidar M et al. found no correlation between any CA6 polymorphism and CA VI catalytic activity, only expression levels. Caries Research, 2013. Instead, the TT genotype produces measurably less CA VI protein secreted into saliva. Individuals with the TT genotype have significantly lower salivary CA VI concentrations compared to CC and CT carriers (p < 0.05). Less enzyme means less bicarbonate generation at the tooth surface — not because each enzyme molecule works poorly, but because fewer molecules are present to do the work.

The Evidence

The association between rs2274327 and salivary buffering was first reported by Peres et al.44 Peres et al.
Peres RC et al. Association of polymorphisms in the carbonic anhydrase 6 gene with salivary buffer capacity, dental plaque pH, and caries index in children aged 7-9 years. Pharmacogenomics Journal, 2010 in 245 Brazilian children aged 7-9: the T allele and TT genotype were significantly underrepresented among children with the highest salivary buffer capacity (p=0.023 and p=0.045, respectively), suggesting that C-allele carriers maintain stronger acid neutralization. Caries experience itself did not significantly differ by genotype in this fluoridated-water cohort, likely reflecting fluoride's protective effect masking the genetic contribution.

The strongest clinical evidence for caries risk comes from Mrag et al.55 Mrag et al.
Mrag M et al. Investigation of carbonic anhydrase 6 gene polymorphism rs2274327 in relation to the oral health status and salivary composition in type 2 diabetic patients. Acta Odontologica Scandinavica, 2020 in a cohort of type 2 diabetic patients, a population with already-compromised salivary function. Patients with the TT genotype had significantly lower salivary pH, buffer capacity, and flow rate (all p < 0.05) and substantially higher DMFT scores, probing pocket depths, and clinical attachment loss. Carrying at least one T allele increased the odds of dental caries (OR 2.59, p < 0.001), xerostomia/dry mouth (OR 2.11, p=0.003), and taste impairment (OR 1.97, p < 0.05).

A negative replication was reported by Sengul et al.66 Sengul et al.
Sengul F et al. CA VI SNP rs2274327 showed no significant association with OHI-S, plaque index, gingival index, salivary flow rate, or salivary pH in 178 Turkish children. Biochemical Genetics, 2016, finding no significant differences between carious and non-carious groups in a healthy pediatric sample. This likely reflects effect modification by diet, fluoride exposure, and oral hygiene masking the genetic effect at the population level.

A broader genomic analysis of 154 Swedish adolescents found that CA6 haploblock variation (haploblock 4 containing rs10864376, rs3737665, and rs12138897) significantly influenced oral microbiota composition and caries risk, with the protective CCC haplotype associated with reduced Streptococcus mutans colonization (OR 0.5) and reduced caries (OR 0.6). rs2274327 falls in haploblock 2, which tags a partially overlapping signal.

The picture that emerges is moderate-strength evidence: the TT genotype consistently reduces salivary CA VI secretion and buffering, but the caries risk consequence is most visible under conditions of high acid challenge or reduced saliva flow (diabetes, dry mouth, high-sugar diet). In adequately fluoridated populations with good oral hygiene, the effect may be largely compensated.

Practical Implications

TT carriers have a structurally weaker salivary acid buffer. The most direct counterstrategies target the two physiological variables most affected: plaque acid load and salivary buffering.

On the acid-load side: limiting the frequency of fermentable carbohydrate exposure matters more than the total amount — eating sweets with meals rather than continuously snacking gives saliva time to recover plaque pH between acid challenges. Xylitol gum or lozenges (5-10 g/day in divided doses) inhibits Streptococcus mutans directly and stimulates salivary flow without providing a fermentable substrate.

On the buffering side: maintaining salivary zinc status supports the CA VI protein pool. Zinc is the essential cofactor for CA VI, and zinc supplementation has been shown to raise salivary CA VI levels in individuals with CA VI deficiency 77 Henkin RI et al. Efficacy of exogenous oral zinc in treatment of patients with carbonic anhydrase VI deficiency. Am J Med Sci, 2000. Professional fluoride application (varnish, high-concentration toothpaste) provides direct enamel protection independent of salivary buffering.

Interactions

rs2274327 sits in haploblock 2 of the CA6 gene alongside rs2274328 and rs17032907. The related rs2274333 (in a different linkage block) affects a separate CA6 variant associated with taste papilla density and PROP taster status. While rs2274327 primarily influences CA VI protein quantity, rs2274333 appears to influence taste bud maintenance. A user carrying risk genotypes at both loci would face both reduced buffering capacity and altered taste sensitivity, but the combined salivary/oral health risk has not been directly studied in a compound heterozygous context. If a compound action is warranted, it would combine the advice for each individual SNP: address both the buffering deficit (fluoride, xylitol, zinc) and the taste perception changes (zinc optimization).

Nutrient Interactions

zinc increased_need

Genotype Interpretations

What each possible genotype means for this variant.

CC Normal Buffering Normal

Normal salivary CA VI secretion and oral acid-buffering capacity

You carry two copies of the C allele, which is associated with the highest salivary carbonic anhydrase VI (CA VI/gustin) concentrations and the strongest salivary buffer capacity. Your saliva produces adequate bicarbonate to neutralize plaque acids efficiently after eating, providing baseline protection against enamel demineralization. About 38% of people globally share this genotype; it is more common in Europeans (~40% CC frequency) and most common in people of African descent (~73% CC frequency due to the lower T allele rate).

CT Reduced Buffering Intermediate

Moderately reduced salivary CA VI — mild impairment of plaque acid neutralization

The heterozygous state produces a mix of Thr55 (C-allele) and Met55 (T-allele) CA6 protein. Because the T-allele form is secreted less efficiently, overall salivary CA VI concentration falls between CC and TT carriers. Studies find that CT individuals have intermediate salivary buffering, but the effect is less pronounced than in TT carriers. The clinical significance is greatest when combined with other risk factors such as frequent sugar consumption, reduced salivary flow (medications, dry mouth), or poor oral hygiene.

TT Significantly Reduced Buffering Reduced

Significantly reduced salivary CA VI — measurably impaired plaque acid neutralization

The TT genotype produces measurably lower concentrations of CA VI protein in saliva — not because each enzyme molecule works less efficiently, but because the Met55 variant form is secreted less effectively from salivary gland acinar cells. The practical consequence is a slower recovery of plaque pH to safe levels (above pH 5.5) after acid exposure. In a healthy person with adequate saliva flow and good oral hygiene, this impairment may be partially masked by fluoride and other protective factors. However, under conditions of high acid challenge (frequent sugar intake, acidic drinks), reduced saliva flow (medications, systemic disease, aging), or pre-existing periodontal disease, the impairment becomes clinically relevant.

Beyond buffering, CA VI plays a role in taste bud maintenance and oral zinc transport, which may explain why the Mrag et al. study found a near-doubling of odds for taste impairment (OR 1.97) in TT carriers. Zinc treatment in individuals with CA VI deficiency has been shown to raise salivary CA VI levels and restore taste function in responders (10 of 14 patients in the Henkin et al. trial, using 100 mg/day zinc for 4-6 months), though whether this extends to TT carriers at normal CA VI levels is not established.